Identification of a novel molecular partner of the E2A gene in childhood leukemia

Leukemia

Volumn 13, Issue 3, 1999, Pages 369-375

  Brambillasca, F ^a   Mosna, G ^a   Colombo, M ^a   Rivolta, A ^b   Caslini, C ^b   Minuzzo, M ^a   Giudici, G ^b   Mizzi, L ^a   Biondi, A ^b   Privitera, E ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c Dipto Genet Biol Microrganismi   (Italy)

Author keywords

E2A; Fusion genes; Pre B ALL

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CHILDHOOD LEUKEMIA; CHROMOSOME 19Q; CHROMOSOME TRANSLOCATION; DISEASE COURSE; FUSION GENE; GENE EXPRESSION; HUMAN; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

EID: 0033045755     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401338     Document Type: Article

References (40)

1. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993; 81: 2237-2251.
2. Hunger SP. Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood 1996; 87: 1211-1224.
3. Mellentin JD, Murre C, Donlon TA, McCaw PS, Smith SD, Carrol AJ, McDonald ME, Baltimore D, Cleary ML. The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. Science 1989; 246: 379-382.
4. Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 1990; 60: 535-545.
5. Kamps MP, Murre C, Sun X-H, Baltimore DA. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 1990; 60: 547-555.
6. Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, Look AT. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 1992; 257: 531-534.
7. Hunger SP, Ohyashiki K, Toyama K, Cleary ML. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev 1992; 6: 1608-1620.
8. Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN, Cabrera CV, Buskin JN, Hauschka SD, Lassar AB, Weintraub H, Baltimore D. Interaction between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 1989; 58: 537-544.
9. Hunger SP, Galili N, Carrol AJ, Crist WJ, Link MP, Cleary ML. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood 1991; 77: 687-693.
10. Privitera E, Kamps MP, Hayashi Y, Inaba T, Shapiro LH, Raimondi SC, Behm F, Hendershot L, Carrol AJ, Baltimore D, Look AT. Different molecular consequences of the 1;19 chromosomal translocation in childhood B cell precursor acute lymphoblastic leukemia. Blood 1992; 79: 1781-1788.
11. Numata S-I, Kato K, Horibe K. New E2A/PBX1 fusion transcript in a patient with t(1;19)(q23;p13) acute lymphoblastic leukemia. Leukemia 1993; 7: 1441-1444.
12. Mellentin JD, Nourse J, Hunger SP, Smith SD, Cleary ML. Molecular analysis of the t(1;19)(q23;p13) breakpoint cluster region in pre-B cell acute lymphoblastic leukemias. Genes Chromos Cancer 1990; 2: 239-247.
13. Hunger SP, Devarai PE, Foroni L, Sacker-Walker LM, Cleary ML. Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL. Blood 1994; 83: 2970-2977.
14. Inukai T, Inaba T, Yoshihara T, Look AT. Cell transformation mediated by homodimeric E2A-HLF transcription factors. Mol Cell Biol 1997; 17: 1417-1424.
15. Hunger SP, Brown R, Cleary ML. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF. Mol Cell Biol 1994; 14: 5986-5996.
16. Kamps MP, Look AT, Baltimore D. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes Dev 1991; 5: 358-368.
17. Fu X, Kamps MP. E2a-Pbx1 induces aberrant expression of tissue specific developmentally regulated genes when expressed in NIH3T3 fibroblasts. Mol Cell Biol 1997; 17: 1503-1512.
18. Knoepfler PS, Kamps MP. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targeting of E2a-Pbx1 to a subset of Pbx-recognition elements. Oncogene 1997; 14: 2521-2531.
19. Inaba T, Inukai T, Yoshihara T, Seyschab H, Ashmun RA, Canman CE, Laken SJ, Kastan MB, Look AT. Reversal of apoptosis by the leukemia-associated E2A-HLF chimaeric transcription factor. Nature 1996; 382: 541-544.
20. Altura RA, Inukai T, Ashmun RA, Zambetti CP, Roussel MF, Look AT. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells. Blood 1998; 92: 1397-1405.
21. De Lau WB, Hurenkamp J, Berendes P, Touw IP, Clevers HC, van Dijk MA. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1. Oncogene 1998; 17: 503-510.
22. Peverali FA, Ramqvist T, Saffric R, Pepperkok R, Barone MV, Philipson L. Regulation of G1 progression by E2A and Id helix-loop-helix proteins. EMBO J 1994; 13: 4291-4301.
23. Baker SJ, Reddy EP. B cell differentiation: role of E2A and Pax5/BSAP transcription factors. Oncogene 1995; 11: 413-426.
24. Prabhu S, Ignatova A, Park ST, Sun XH. Regulation of the expression of cyclin dependent kinase inhibitor p21 by E2A and Id proteins. Mol Cell Biol 1997; 17: 5888-5896.
25. Bain G. Maandag ECR, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, vanRoon M, van der Valk M, te Riele HPJ, Berns A, Murre C. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 1994; 79: 885-892.
26. Zhuang Y, Soriano P, Weintraub H. The helix-loop-helix gene E2A is required for B cell formation. Cell 1994; 79: 875-884.
27. Shen C-P, Kadesch T. B-cell-specific DNA binding by an E47 homodimer. Mol Cell Biol 1995; 15: 4518-4524.
28. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-cloroform extraction. Anal Biochem 1987; 162: 156-160.
29. Tosi S, Giudici G, Mosna G, Harbott J, Specchia G, Grosveld G, Privitera E, Kearney L, Biondi A, Cazzaniga G. Identification of new partner chromosomes involved in fusions with the ETV6 (Tel) gene in hematologic malignancies. Genes Chromos Cancer 1998; 21: 223-229.
30. www-bio.llnl.gov/bbrp/genome.
31. Privitera E, Luciano A, Ronchetti D, Aricò M, Santostasi T, Basso G, Biondi A. Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL). Leukemia 1994; 8: 554-559.
32. Takeuchi S, Bartram CR, Wada M, Reiter A, Hatta Y, Seriu T, Lee E, Miller CW, Miyoshi I, Koeffler HP. Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res 1995; 55: 5377-5382.
33. Maintz D, Fiedler K, Koopmann J, Rollbrocker B, Nechev S, Lenartz D, Stangl AP, Louis DN, Schramm J, Wiestler OD, von Deimling A. Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 1997; 56: 1098-1104.
34. Bicher A, Adult K, Kimmelman A, Gershenson D, Reed E, Liang B. Loss of heterozygosity in human ovarian cancer on chromosome 19q. Gynecol Oncol 1997; 66: 36-40.
35. McDonald JM, Douglass EC, Fisher R, Geiser CF, Krill CE, Strong LC, Virshup D, Huff V. Linkage of familial Wilms' tumor predisposition to chromosome 19 and two-locus model for the etiology of familial tumors. Cancer Res 1998; 58: 1387-1390.
36. Mehenni H, Blouin J-L, Radhakrishna U, Bhardwaj SS, Bhardwaj K, Dixit VB, Richards KF, Bermejo-Fenoll A, Leal AS, Raval RC, Antonarakis SE. Peutz-Jeghers syndrome. Confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4. Am J Hum Genet 1997; 61: 1327-1334.
37. Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffè M, Jonveaux P, Macyntire EA, Berger R, Bernard OA. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995; 86: 4263-4267.
38. Aronheim A, Shiran R, Rosen A, Walker MD. The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc Natl Acad Sci USA 1993; 90: 8063-8067.
39. Monika K, LeBrun DP, Dedera DA, Brown R, Cleary ML. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol Cell Biol 1994; 14: 8304-8310.
40. Inukai T, Inaba T, Ikushima S, Look AT. The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF. Mol Cell Biol 1998; 18: 6035-6043.